A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma
{{output}}
Background & aims: Chemoimmunotherapy has emerged as the first-line therapy for unresectable intrahepatic cholangiocarcinoma (ICC). However, durable clinical responses are observed in less than 30% of patients, necessitating biom... ...
